Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. (ATNM) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 168 transactions totaling $2.1M, demonstrating a bearish sentiment with -$1.7M in net insider flow. The most recent transaction on Aug 18, 2025 involved a transaction of 120,900 shares valued at $206.7K.
ATNM Insider Activity Summary
Who Is Buying ATNM Stock?
No significant insider buying has been recorded for ATNM in the recent period.
Who Is Selling ATNM Stock?
No significant insider selling has been recorded for ATNM in the recent period.
Is Actinium Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ATNM is bearish with an Insider Alignment Score of 8/100 and a net flow of -$1.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
ATNM Frequently Asked Questions
Understanding ATNM Insider Activity
Insider trading at Actinium Pharmaceuticals, Inc. (ATNM) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ATNM stock, having executed 168 transactions in the past 90 days. The most active insider is Sloan-kettering Cancer Center Memorial (Executive), who has made 120 transactions totaling $1.9M.
Related Tools
Track Actinium Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at ATNM file new Form 4 transactions